Becker's Healthcare April 19, 2024
HHS has finalized a rule to establish a 340B administrative dispute resolution process as required under the Affordable Care Act.
The ADR process allows all 340B-covered entities — regardless of the size of the organization or monetary value of the claim — to address claims at dispute with drug companies, according to the American Hospital Association.
The new process will include 340B program subject matter experts from the Health Resources and Services Administration’s office of pharmacy affairs, allow covered entities to bring claims where they have been overcharged by a drug company including where the company or its wholesaler denies access to 340B pricing and require decisions be reached by the ADR process within one year of submission of...
Today's Sponsors
Today's Sponsor